UMIN ID: UMIN000055681
Registered date:01/10/2024
Exploring Prognostic Factors for Heavy Ion Therapy of Bone and Soft Tissue Sarcomas
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Bone and Soft Tissue Sarcoma |
| Date of first enrollment | 2024/09/13 |
| Target sample size | 150 |
| Countries of recruitment | Japan |
| Study type | Others,meta-analysis etc |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Analysis of blood components using blood samples taken before the start of treatment, on the 11th day of treatment, and after the end of treatment on the last day of treatment. Whenever possible, the same analysis will be done during follow-up visits within 5 years of the end of treatment. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients who are judged by the investigator or other physicians to be inappropriate to participate in this study. |
Related Information
| Primary Sponsor | National Institutes for Quantum Science and Technology |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | National Institutes for Quantum Science and Technology |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Reiko Imai |
| Address | Anagawa4-9-1, Inage-ku, Chiba Japan 263-8555 |
| Telephone | 043-206-3306 |
| imai.reiko@qst.go.jp | |
| Affiliation | National Institutes for Quantum Science and Technology QST Hospital, Radiation Oncology Promotion Section |
| scientific contact | |
| Name | Takashi Shimokawa |
| Address | Anagawa4-9-1, Inage-ku, Chiba Japan |
| Telephone | 043-206-4048 |
| shimokawa.takashi@qst.go.jp | |
| Affiliation | National Institutes for Quantum Science and Technology Institute for Quantum Medical Science, Department of Accelerator and Medical Physics |